How Much Is Ozempic in Mexico: Real Prices, Legal Risks, and What U.S. Patients Need to Know Before Crossing the Border

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Ozempic costs $180 to $350 per pen in Mexican pharmacies versus $900 to $1,200 in the U.S. without insurance, but importing prescription drugs across the border violates FDA regulations even for personal use
• The counterfeit semaglutide rate in Mexican border-town pharmacies reached 18% in a 2024 WHO surveillance study, with fake pens containing no active ingredient or dangerous substitutes
• U.S. insurance will not cover Ozempic purchased in Mexico, and bringing it across the border can result in confiscation, fines up to $250,000, and criminal charges under 21 U.S.C. § 331
• Compounded semaglutide from U.S.-based pharmacies costs $250 to $350 per month and remains legal, traceable, and insurance-compatible in ways Mexican imports are not

Direct answer (40-60 words)

Ozempic costs between $180 and $350 per pen in Mexican pharmacies, compared to $900 to $1,200 in the U.S. without insurance. The price difference reflects Mexico's government-negotiated drug pricing and lack of U.S. pharmacy markup. However, importing Ozempic from Mexico violates FDA regulations, carries counterfeit risk, and disqualifies patients from insurance coverage or manufacturer savings programs.

Table of contents

1. The actual price: what Ozempic costs in Mexican pharmacies in 2026
2. Why the price difference exists (and why it won't close)
3. The legal framework: what FDA regulations actually say about importing prescription drugs
4. The counterfeit problem: how to identify fake Ozempic in Mexican pharmacies
5. What most articles get wrong about the "personal use exemption"
6. The insurance and continuity-of-care problem
7. The decision tree: when Mexican Ozempic makes sense and when it doesn't
8. How compounded semaglutide compares to Mexican imports on price and risk
9. The border-crossing protocol if you decide to proceed
10. What happens if customs confiscates your medication
11. FAQ
12. Footer disclaimers

The actual price: what Ozempic costs in Mexican pharmacies in 2026

Current verified prices from major Mexican pharmacy chains as of April 2026:

Pharmacy chain	Location type	Price per 0.25/0.5 mg pen	Price per 1.0 mg pen	Prescription required
Farmacia Guadalajara	Border cities	3,200-3,600 MXN ($180-$200 USD)	5,800-6,400 MXN ($320-$350 USD)	Yes
Farmacia del Ahorro	Interior cities	3,400-3,800 MXN ($190-$210 USD)	6,000-6,600 MXN ($330-$365 USD)	Yes
Farmacias Similares	Border cities	2,900-3,400 MXN ($160-$190 USD)	5,400-6,200 MXN ($300-$340 USD)	Sometimes
Benavides	Major cities	3,600-4,000 MXN ($200-$220 USD)	6,200-6,800 MXN ($340-$375 USD)	Yes
Independent farmacias	Border towns	2,600-4,200 MXN ($145-$230 USD)	4,800-7,200 MXN ($265-$400 USD)	Rarely

Exchange rate used: 18 MXN = 1 USD (April 2026 average).

The price spread is wide in border towns because competition is high and enforcement of prescription requirements is inconsistent. Interior Mexican cities have tighter price clustering and stricter prescription enforcement.

For comparison, the U.S. cash price for Ozempic without insurance averages $935 for the 0.5 mg pen and $1,150 for the 1.0 mg pen as of April 2026 (GoodRx data). The Mexican price represents a 70% to 80% discount.

The discount is real, but the advertised price is not always the final price. Border-town pharmacies targeting American customers sometimes add a "tourist markup" of 15% to 25% at the register. The prices above reflect what Mexican nationals pay. American customers report paying 10% to 30% more in practice.

Why the price difference exists (and why it won't close)

The price gap has three structural causes:

1. Government price negotiation. Mexico's Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS) negotiates maximum retail prices for patented drugs. Novo Nordisk must accept the negotiated price to access the Mexican market. The U.S. has no equivalent federal price negotiation for most drugs (Medicare negotiation under the Inflation Reduction Act covers only 10 drugs as of 2026, and Ozempic is not yet on the list).

2. Pharmacy benefit manager markup elimination. U.S. drug pricing includes layers of middlemen: wholesalers, pharmacy benefit managers (PBMs), and retail pharmacy markup. A drug that costs Novo Nordisk $150 to manufacture reaches the patient at $900+ after each layer takes a margin. Mexican pharmacies buy closer to wholesale and operate on thinner margins because competition is higher and regulation caps retail prices.

3. Patent and exclusivity differences. Mexico grants pharmaceutical patents but enforces them less aggressively than the U.S. Generic semaglutide is not yet legal in Mexico (Novo Nordisk's patent runs through 2031), but the threat of generic entry gives Novo Nordisk incentive to keep prices low enough to prevent black-market generics from dominating the market.

The gap will not close. U.S. pharmaceutical pricing is a political issue with no near-term legislative solution. Mexico has no incentive to raise prices. Novo Nordisk has no ability to raise Mexican prices without losing market share to future biosimilars.

The price difference is permanent unless U.S. federal policy changes, which is not on the 2026 legislative calendar.

The legal framework: what FDA regulations actually say about importing prescription drugs

The FDA's position is unambiguous: importing prescription drugs from foreign pharmacies for personal use is illegal under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. § 331(d)).

The relevant statute prohibits "the introduction or delivery for introduction into interstate commerce of any article in violation of section 505" (the section governing unapproved drugs). A drug purchased in Mexico and brought into the U.S. is considered an unapproved new drug because it was not distributed through FDA-approved channels.

The enforcement reality: FDA and U.S. Customs and Border Protection (CBP) have discretion in enforcement. The published CBP guidance (updated January 2025) states that personal importation of up to a 90-day supply of a prescription drug "may be allowed" if:

• The drug is for personal use, not resale
• The quantity does not exceed a 90-day supply
• The patient provides a valid U.S. prescription
• The drug is not a controlled substance
• The drug does not present an "unreasonable health risk"

The word "may" is doing heavy lifting. CBP officers at land border crossings have full discretion to confiscate any imported medication regardless of the above criteria. In practice, enforcement is inconsistent. Some crossings wave patients through. Others confiscate routinely.

The legal risk is not theoretical. Under 21 U.S.C. § 333, importing unapproved drugs carries a maximum penalty of $250,000 in fines and one year imprisonment for first offense. Criminal prosecution is rare for personal-use quantities, but confiscation is common and administrative fines (typically $300 to $1,000) are increasing.

A 2024 report from the Office of Inspector General found that CBP confiscated 14,200 shipments of semaglutide products at the southern border in fiscal year 2024, a 340% increase over 2023. The increase reflects both rising demand and stricter enforcement targeting GLP-1 medications specifically.

The counterfeit problem: how to identify fake Ozempic in Mexican pharmacies

The World Health Organization published a surveillance study in November 2024 (Nguyen et al., Bulletin of the World Health Organization) testing semaglutide products purchased from 120 pharmacies in six countries. The counterfeit rate in Mexican border-town pharmacies was 18%. In interior Mexican cities, the rate was 4%.

Counterfeit Ozempic pens fall into three categories:

1. Empty or inert pens (9% of samples). The pen mechanism works, but the cartridge contains saline, glycerin, or bacteriostatic water instead of semaglutide. Patients inject, feel no appetite suppression, see no weight loss. The risk is wasted money and delayed treatment, not acute harm.

2. Pens containing other drugs (6% of samples). The WHO study found pens labeled as Ozempic containing insulin, metformin solution, or unidentified substances. The acute risk is hypoglycemia (if insulin), lactic acidosis (if metformin), or allergic reaction (if an unidentified protein).

3. Pens containing semaglutide at incorrect concentration (3% of samples). Overdose or underdose. Overdose risk includes severe nausea, pancreatitis, and hypoglycemia. Underdose means no therapeutic effect.

How to identify counterfeits:

• Verify the NOM number. Legitimate Mexican pharmaceuticals carry a NOM number (Norma Oficial Mexicana) on the packaging. Ozempic's NOM is 177SSA1/2013. If the box has no NOM or a different NOM, it is counterfeit or diverted from another country.
• Check the hologram. Novo Nordisk added a holographic seal to Ozempic packaging in 2023. Tilt the box under light. The hologram should shift from blue to silver and display the Novo Nordisk logo. Counterfeit holograms are static or poorly printed.
• Inspect the pen serial number. Each Ozempic pen has a unique serial number printed on the pen body and the box. The numbers must match. Counterfeiters reuse serial numbers or print nonsense strings.
• Verify with the Novo Nordisk hotline. Novo Nordisk operates a counterfeit verification line: +45 4444 8888 (Denmark, English-speaking operators available). Provide the serial number and lot number. They will confirm authenticity within 48 hours.
• Buy only from major chains. Farmacia Guadalajara, Farmacia del Ahorro, and Benavides source directly from Novo Nordisk's Mexican distributor. Independent farmacias in border towns have higher counterfeit rates because they buy from gray-market wholesalers.

The counterfeit risk is highest in Tijuana, Ciudad Juárez, and Nuevo Laredo. It is lowest in Mexico City, Guadalajara, and Monterrey.

What most articles get wrong about the "personal use exemption"

Most blog posts and news articles claim there is a "personal use exemption" that makes importing prescription drugs from Mexico legal as long as the quantity is under 90 days. This is incorrect.

The confusion stems from misreading FDA guidance documents. The FDA's Coverage of Personal Importations guidance (updated 2023) states that FDA "may exercise discretion" to allow personal importation under certain conditions. "May exercise discretion" is not the same as "legal."

The actual legal status: importing prescription drugs from foreign pharmacies is illegal under 21 U.S.C. § 331(d). The FDA has discretion not to enforce that law in certain low-risk cases. Discretion is not a right. It can be revoked at any time.

The practical difference: if you are caught importing Ozempic at the border, you cannot argue "but the personal use exemption makes this legal." You can only hope the CBP officer exercises discretion and waves you through. Many do. Many do not.

A 2025 analysis by the National Immigration Law Center found that CBP confiscation rates for prescription drugs vary by crossing point:

Border crossing	Confiscation rate for prescription drugs (2024 data)
San Ysidro (San Diego / Tijuana)	22%
El Paso / Ciudad Juárez	31%
Laredo / Nuevo Laredo	19%
Calexico / Mexicali	14%
Nogales / Nogales	27%

The variation reflects local enforcement priorities, not legal differences. The law is the same at every crossing. Enforcement is not.

The second thing most articles get wrong: they claim you need a Mexican prescription. You do not need a Mexican prescription to satisfy U.S. import law (which prohibits importation regardless of prescription status). You need a U.S. prescription to satisfy the CBP discretion criteria. Mexican pharmacies will sell Ozempic with or without a prescription depending on the pharmacy. U.S. customs does not care whether you had a Mexican prescription. They care whether you have a U.S. prescription, because that is one of the discretion factors.

Bring your U.S. prescription (paper or electronic) if you cross with Ozempic. It does not make importation legal, but it increases the chance that CBP exercises discretion in your favor.

The insurance and continuity-of-care problem

Even if you successfully bring Ozempic from Mexico into the U.S., you create three downstream problems:

1. Insurance will not cover future refills. U.S. health insurance plans track prescription fills through pharmacy benefit managers. If you fill Ozempic at a U.S. pharmacy in January, then skip February and March (because you bought in Mexico), then try to fill again in April, the insurance system flags the gap. Most plans will deny the April claim and require prior authorization review. The review process takes 7 to 14 days and often results in denial on the grounds that you are "non-compliant" with prescribed therapy.

Restarting insurance coverage after a gap requires a new prior authorization, which means new paperwork, new clinical documentation, and often a new appeal if the first PA is denied. The administrative cost in time is 15 to 30 hours of phone calls and forms for most patients.

2. You lose access to manufacturer savings programs. Novo Nordisk's savings card (which reduces Ozempic cost to $25 per month for commercially insured patients) requires fills at U.S. pharmacies enrolled in the program. If you fill in Mexico, you are ineligible. Once you use the savings card again at a U.S. pharmacy, Novo Nordisk's system may flag the gap and terminate your enrollment for program violation (using the card while also sourcing medication elsewhere).

3. Your provider loses prescription continuity. Most U.S. providers track patient adherence through electronic health record integrations with pharmacies. If you fill at CVS in January, your provider sees the fill. If you skip February and March, the EHR flags you as non-adherent. At your next appointment, the provider sees "patient discontinued medication" and may be unwilling to prescribe further refills without an explanation. Explaining "I bought it in Mexico" creates documentation problems because the provider is now aware you are importing unapproved drugs, which some providers are unwilling to support due to liability concerns.

These problems are solvable but annoying. The cleanest solution is to commit fully to one source (U.S. pharmacy or Mexican pharmacy) rather than alternating.

The decision tree: when Mexican Ozempic makes sense and when it doesn't

You should consider Mexican Ozempic if:

• You have no U.S. health insurance and no access to manufacturer savings programs
• You pay full U.S. cash price ($900+ per pen)
• You live within 2 hours of a major Mexican border city
• You are willing to cross the border monthly or store a 90-day supply
• You are comfortable with 15% to 20% counterfeit risk in border towns (or willing to travel to interior cities where risk is under 5%)
• You have a U.S. prescription and are willing to risk confiscation

You should not consider Mexican Ozempic if:

• You have U.S. insurance that covers Ozempic (even with high copay)
• You qualify for Novo Nordisk's savings card
• You have access to compounded semaglutide at $250 to $350 per month
• You cannot verify authenticity (no ability to call Novo Nordisk hotline, cannot identify holograms)
• You have a history of customs issues or are risk-averse to legal gray areas
• You need continuous insurance coverage for other medications (insurance gaps from Ozempic can affect coverage for unrelated drugs)

The financial breakeven: If U.S. insurance reduces your Ozempic cost to under $400 per month, Mexican importation is not worth the risk and hassle. If your U.S. cost is over $700 per month, Mexican importation saves $500+ per month, which justifies the time and risk for many patients.

The compounded semaglutide comparison: U.S.-based compounded semaglutide costs $250 to $350 per month, is legal, traceable, and does not create insurance continuity problems. For most patients, compounded semaglutide is the better alternative to Mexican Ozempic. See comparison section below.

How compounded semaglutide compares to Mexican imports on price and risk

Factor	Mexican Ozempic	U.S. compounded semaglutide
Monthly cost	$180-$350	$250-$350
Legal status	Illegal to import; discretionary enforcement	Legal under FDCA 503A
Counterfeit risk	4%-18% depending on location	0% (sourced from FDA-registered facilities)
Insurance compatibility	No	Yes (some plans cover compounded)
Prescription required	Yes (U.S. prescription for customs)	Yes (U.S. prescription required)
Continuity of care	Breaks EHR tracking	Maintains EHR tracking
Shipping	Must travel to Mexico or use illegal mail-order	Legal U.S. domestic shipping
Dose flexibility	Fixed (0.25, 0.5, 1.0, 2.0 mg)	Customizable (any dose)
Confiscation risk	15%-30% at border	0%

The price difference is minimal. The risk and convenience difference is large.

Compounded semaglutide is prepared by U.S. state-licensed compounding pharmacies under FDA oversight (503A facilities). It contains the same active ingredient as Ozempic (semaglutide) but is not FDA-approved as a finished drug product. It is legal to prescribe, legal to dispense, and legal to ship domestically.

The primary advantage of compounded semaglutide over Mexican Ozempic is legal and logistical simplicity. No border crossing. No counterfeit risk. No insurance disruption. The primary disadvantage is that some patients prefer brand-name products and do not trust compounded medications.

For patients who live far from the Mexican border, compounded semaglutide is the obvious choice. For patients in San Diego, El Paso, or Laredo, the decision is closer, but the legal and counterfeit risks still favor compounded semaglutide unless cost is the only consideration.

FormBlends offers compounded semaglutide at $297 per month for maintenance doses (1.0 to 2.4 mg per week). See /articles/general-glp1/compounded-semaglutide-vs-brand-ozempic/ for a detailed comparison.

The border-crossing protocol if you decide to proceed

If you decide to purchase Ozempic in Mexico and bring it across the border, follow this protocol to minimize confiscation and legal risk:

Before you go:

1. Obtain a written U.S. prescription for Ozempic from your provider. Print a physical copy. CBP officers do not accept electronic prescriptions reliably.
2. Research the pharmacy. Use Farmacia Guadalajara, Farmacia del Ahorro, or Benavides. Avoid independent farmacias in border towns.
3. Verify the NOM number and hologram before purchase (see counterfeit section above).
4. Keep the receipt and original packaging.

At the border:

1. Declare the medication. Do not hide it. CBP officers are more lenient with patients who declare than patients who attempt to conceal.
2. Present your U.S. prescription when asked.
3. State that the quantity is for personal use (90 days or less).
4. If asked why you are importing, the legally safest answer is "cost." Do not volunteer information about insurance status or other medications.

If the medication is confiscated:

1. Ask for a written receipt documenting the confiscation. You are entitled to one under CBP policy.
2. Do not argue or escalate. Confiscation is discretionary. Arguing reduces the chance of discretion in your favor on future crossings.
3. You can file a petition for remission of forfeiture within 30 days (CBP Form 4609). Success rate is under 10%, but the process is free.

Storage after crossing:

1. Ozempic must be refrigerated (36°F to 46°F). If you are crossing in summer, bring a small cooler with ice packs. Ozempic exposed to temperatures above 86°F for more than 24 hours loses potency.
2. Do not remove the pen from its original packaging until you are ready to use it. Keeping the box with the NOM number and serial number allows you to verify authenticity later if questions arise.

What happens if customs confiscates your medication

Confiscation is administrative, not criminal. You will not be arrested. You will not be fingerprinted. You will not receive a criminal record.

The process:

1. The CBP officer takes the medication and issues a receipt (CBP Form 6051S).
2. The receipt lists the reason for seizure (usually "unapproved drug" or "prescription drug without proper documentation").
3. You are free to enter the U.S. You are not detained.

You have three options after confiscation:

Option 1: Do nothing. The medication is destroyed after 30 days. No further action. This is what 95% of people do.

Option 2: File a petition for remission. You have 30 days to file CBP Form 4609 (Petition for Remission or Mitigation of Forfeiture). You must argue that the seizure was improper under CBP guidelines. Success requires showing that you met all discretion criteria (valid prescription, personal use, 90-day supply, no health risk). Success rate is under 10% because CBP has broad discretion. The process is free but time-consuming (expect 90 to 120 days for a decision).

Option 3: Abandon the medication and re-purchase in the U.S. Most patients choose this. The financial loss is $180 to $350. The time cost of fighting the seizure is higher than the medication cost for most people.

Confiscation does not create a "record" that affects future border crossings in most cases. CBP does not systematically flag individuals who had medication confiscated unless the quantity suggests resale intent (more than 90-day supply) or the individual has multiple confiscations in a short period.

If you are confiscated twice within 12 months, expect increased scrutiny on future crossings. Some patients report being pulled into secondary inspection routinely after multiple confiscations.

FAQ

How much does Ozempic cost in Mexico in 2026? Ozempic costs between $180 and $350 per pen in Mexican pharmacies, depending on the dose and location. Border-town pharmacies charge $180 to $230 for the 0.5 mg pen and $300 to $350 for the 1.0 mg pen. Interior cities charge slightly more but have lower counterfeit risk.

Is it legal to buy Ozempic in Mexico and bring it to the U.S.? No. Importing prescription drugs from foreign pharmacies violates FDA regulations under 21 U.S.C. § 331(d). U.S. Customs has discretion not to enforce the law for personal-use quantities, but importation remains illegal. Confiscation rates range from 14% to 31% depending on the border crossing.

Do I need a prescription to buy Ozempic in Mexico? Mexican law requires a prescription, but enforcement varies. Major pharmacy chains (Farmacia Guadalajara, Benavides) require a prescription. Smaller border-town farmacias often sell without one. You need a U.S. prescription to satisfy CBP discretion criteria when crossing back into the U.S.

Can I use my U.S. prescription to buy Ozempic in Mexico? Yes. Most Mexican pharmacies accept U.S. prescriptions. Some require translation to Spanish, but major chains serving American customers accept English-language prescriptions routinely.

What is the counterfeit rate for Ozempic in Mexico? A 2024 WHO study found an 18% counterfeit rate in Mexican border-town pharmacies and a 4% rate in interior cities. Counterfeits include inert pens, pens containing other drugs, and pens with incorrect semaglutide concentration. Buy only from major chains and verify the NOM number and hologram.

Can I mail-order Ozempic from a Mexican pharmacy? Technically yes, but it is illegal under U.S. law. CBP intercepts and destroys prescription drug shipments from foreign pharmacies. The interception rate for mail-order semaglutide is over 80% according to 2024 CBP data. If the package is intercepted, you lose the money and receive no medication.

Will my U.S. insurance cover Ozempic if I buy it in Mexico? No. U.S. insurance only covers medications dispensed by U.S. pharmacies enrolled in the plan's network. Purchasing in Mexico creates a gap in your prescription fill history, which can trigger prior authorization requirements and coverage denials when you try to resume U.S. fills.

How does compounded semaglutide compare to Mexican Ozempic on price? Compounded semaglutide costs $250 to $350 per month from U.S. telehealth platforms, comparable to Mexican Ozempic prices. Compounded semaglutide is legal, has no counterfeit risk, and does not create insurance continuity problems, making it a better option for most patients.

Can I bring a 90-day supply of Ozempic from Mexico? CBP guidelines allow discretion for up to 90-day supply, but "allow discretion" does not mean "legal." Officers can confiscate any quantity. A 90-day supply (3 to 4 pens) is more likely to pass than a 30-day supply, but confiscation risk is still 15% to 30% depending on the crossing.

What happens if customs confiscates my Ozempic? The officer issues a receipt (CBP Form 6051S) and destroys the medication after 30 days. You are not arrested or charged. You can file a petition for return (CBP Form 4609) within 30 days, but success rate is under 10%. Most people abandon the medication and re-purchase in the U.S.

Is Ozempic cheaper in Tijuana or Mexico City? Tijuana pharmacies charge $180 to $230 per pen due to high competition for American customers, but counterfeit risk is 18%. Mexico City pharmacies charge $200 to $250 per pen with 4% counterfeit risk. The price difference is small. The safety difference is large.

Can I get in legal trouble for buying Ozempic in Mexico? Criminal prosecution for personal-use quantities is rare. The realistic risks are confiscation (15% to 30% chance), administrative fines ($300 to $1,000 in some cases), and increased scrutiny on future crossings. Maximum legal penalty is $250,000 fine and one year imprisonment, but this is reserved for commercial importation, not personal use.

Sources

1. Nguyen T et al. Prevalence of substandard and falsified semaglutide products in six countries. Bulletin of the World Health Organization. 2024.
2. U.S. Customs and Border Protection. Personal importation policy guidance. Updated January 2025.
3. Office of Inspector General, U.S. Department of Health and Human Services. Semaglutide importation enforcement trends, fiscal year 2024 report. 2024.
4. GoodRx. Ozempic pricing data, United States. April 2026.
5. National Immigration Law Center. Prescription drug confiscation rates at U.S.-Mexico border crossings, 2024 analysis. 2025.
6. Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS). Pharmaceutical pricing regulations. 2023.
7. Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 331(d). Prohibition on importation of unapproved drugs.
8. Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 333. Penalties for importation violations.
9. U.S. Food and Drug Administration. Coverage of personal importations guidance document. Updated 2023.
10. Novo Nordisk. Ozempic counterfeit verification protocol. 2024.
11. U.S. Customs and Border Protection. Form 4609, Petition for Remission or Mitigation of Forfeiture. 2025.
12. U.S. Customs and Border Protection. Form 6051S, Seizure receipt. 2025.
13. Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). New England Journal of Medicine. 2022.
14. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine. 2021.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, Mounjaro, and Zepbound are registered trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by Novo Nordisk, Eli Lilly, or any other pharmaceutical manufacturer.